Updated: January 29, 2026
Alternatives to Omnitrope If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Why Consider an Alternative to Omnitrope?
- Norditropin (Novo Nordisk) — Most Widely Prescribed Brand
- Genotropin (Pfizer) — Multiple Delivery Options
- Humatrope (Eli Lilly) — Unique SHOX Indication
- Saizen (Merck) — Less Common but Available
- Skytrofa (Ascendis Pharma) — Once-Weekly Option for Children
- How to Ask Your Doctor About Switching
- The Bottom Line
Can't fill your Omnitrope prescription? Learn about Norditropin, Genotropin, Humatrope, and other somatropin alternatives your doctor may be able to prescribe.
If your Omnitrope prescription is stuck in a prior authorization loop, unavailable at your specialty pharmacy, or simply too expensive without coverage, you have options. Omnitrope (somatropin) is one of several FDA-approved growth hormone medications that all contain the same active ingredient. Your endocrinologist may be able to switch you to an alternative that is covered by your insurance or more readily available.
This guide explains the most common Omnitrope alternatives, how they compare, and what to discuss with your doctor.
Why Consider an Alternative to Omnitrope?
There are several situations where your doctor might recommend switching from Omnitrope to another growth hormone brand:
- Your insurance plan doesn't cover Omnitrope but covers another brand (formulary preference)
- Omnitrope is not available at your designated specialty pharmacy
- Prior authorization for Omnitrope is denied but another brand is approved
- Your step therapy requirement mandates trying a different brand first
- You prefer a different delivery device (e.g., a prefilled pen rather than a cartridge system)
Norditropin (Novo Nordisk) — Most Widely Prescribed Brand
Norditropin is the most commonly prescribed growth hormone in the United States and is often on the preferred formulary tier for commercial insurers and Medicare Part D plans. It comes in a convenient FlexPro prefilled pen in 5 mg/1.5 mL, 10 mg/1.5 mL, 15 mg/1.5 mL, and 30 mg/3 mL strengths (note: the 30 mg/3 mL was discontinued in late 2025). Norditropin's all-in-one prefilled pen design eliminates the need for separate cartridges and pens, which some patients find simpler.
Norditropin is FDA-approved for pediatric GHD, adult GHD, Turner Syndrome, Noonan Syndrome, Small for Gestational Age, and Idiopathic Short Stature. It covers all the same indications as Omnitrope.
Genotropin (Pfizer) — Multiple Delivery Options
Genotropin is made by Pfizer and is available in the Genotropin Pen (5 mg and 12 mg cartridges) and Genotropin MiniQuick single-dose injectors (0.2 mg through 2 mg). The MiniQuick doesn't require refrigeration for up to 3 months — a significant advantage for traveling patients or those with limited refrigerator access. Pfizer significantly scaled up Genotropin production during the broader somatropin shortage beginning in 2022.
Genotropin is FDA-approved for pediatric GHD, PWS, SGA, Turner Syndrome, ISS, adult GHD, and SHOX deficiency.
Humatrope (Eli Lilly) — Unique SHOX Indication
Humatrope is manufactured by Eli Lilly and comes in 6 mg, 12 mg, and 24 mg cartridges used with a HumatroPen device. It is one of the few somatropin brands specifically FDA-approved to treat short stature associated with SHOX (Short Stature Homeobox) gene deficiency — an indication not shared by Omnitrope. If your child has SHOX deficiency, Humatrope may be the preferred option.
Saizen (Merck) — Less Common but Available
Saizen, made by EMD Serono (a Merck subsidiary), uses a click.easy auto-injector or needle-free easypod device and is available in 5 mg and 8.8 mg vials. It's not as commonly preferred on formularies, but some patients use it successfully. It covers pediatric GHD, Turner Syndrome, adult GHD, and ISS.
Skytrofa (Ascendis Pharma) — Once-Weekly Option for Children
Skytrofa (lonapegsomatropin-tcgd) is a different type of growth hormone therapy — it's a long-acting somatropin prodrug that delivers a week's worth of growth hormone from a single weekly injection. It is FDA-approved for pediatric GHD only (not adults). For families struggling with daily injection compliance, Skytrofa may be worth discussing with your pediatric endocrinologist. However, it is not a direct substitute for all Omnitrope indications.
How to Ask Your Doctor About Switching
All somatropin products contain the same active ingredient and work through the same mechanism, so switching between brands is generally medically straightforward. Here's how to approach the conversation with your endocrinologist:
- Bring your insurance formulary: Show your doctor which brands are on the preferred tier for your plan.
- Ask about equivalent dosing: Doses are weight-based and calculated the same way for all daily somatropin brands. Your doctor can determine the equivalent dose.
- Confirm the indication is covered: Not all brands are approved for all indications. For example, SHOX deficiency is covered by Humatrope but not Omnitrope.
- Learn the new device: Different brands use different pens and cartridges. Expect to re-train on the new delivery system.
The Bottom Line
If you can't fill Omnitrope, you are not out of options. Norditropin, Genotropin, Humatrope, and other somatropin brands all use the same active ingredient and can be substituted with your doctor's guidance. Before switching, check which brand your insurance prefers — this single step can save hundreds of dollars and weeks of delay. And if you'd rather find Omnitrope at a pharmacy near you, use medfinder to locate it quickly. Also read: Why is Omnitrope so hard to find?.
Frequently Asked Questions
Yes, with your doctor's guidance. Both Omnitrope and Norditropin contain somatropin as the active ingredient. Switching is medically straightforward, but requires a new prescription and potentially a new prior authorization from your insurer. Your doctor will calculate an equivalent weight-based dose.
Both contain somatropin (recombinant human growth hormone) with the same 191-amino-acid sequence. They are therapeutically equivalent for most indications. However, they use different delivery devices (cartridges, pens) and are made by different manufacturers (Sandoz vs. Pfizer). Your insurance may cover one but not the other.
All brand-name somatropin products are expensive without insurance. Omnitrope itself has one of the most comprehensive self-pay programs at $19/mg through OmniSource. Among alternatives, Norditropin is often preferred on formularies, which can lower your copay. Discuss options with your doctor and insurance to find the lowest out-of-pocket cost for your situation.
Yes. Skytrofa (lonapegsomatropin-tcgd) is a once-weekly injectable growth hormone approved for pediatric GHD. It may be suitable for children struggling with daily Omnitrope injections. It is not approved for adult GHD. Ask your pediatric endocrinologist if Skytrofa is right for your child.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Omnitrope also looked for:
More about Omnitrope
36,651 have already found their meds with Medfinder.
Start your search today.





